Critical Capital, Inc. – Trademark Portfolio
Entity Type: 03
Critical Capital, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 7 Nice Classification classes. The owner is based in Reno, NV.
1155 W. 4th Street Suite 214
Reno, NV 89503
Showing of trademarks Trademarks
Trademark Classifications
Critical Capital, Inc.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Critical Capital, Inc. have?
Critical Capital, Inc. has 5 U.S. trademarks filed with the USPTO.
What trademark classes does Critical Capital, Inc. file in?
Critical Capital, Inc. files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Critical Capital, Inc.'s trademark registration success rate?
Critical Capital, Inc. has a 0% trademark registration rate, with 0 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.